Bicyclic [3.1.0] derivatives as glycine transporter inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/14 (2006.01) A61K 31/5377 (2006.01)

Patent

CA 2542279

The present invention relates to a series of substituted bicyclic [3.1.0]amines of the Formula I: Wherein A, B, D, Q, V, W, X, Y, Z, R2, R3, R4, R5, R14, R15, R30.o, p, s, t and q are as defined in the specification, their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and their use for the enhancement of cognition and the treatment of the positive and negative symptoms of schizophrenia and other psychoses in mammals, including humans.

L'invention concerne une série d'amines [3.1.0] bicycliques substituées de formule (I), dans laquelle A, B, D, Q, V, W, X, Y, Z, R?2¿, R?3¿, R?4¿, R?5¿, R?14¿, R?15¿, R?30¿, o, p, s, t et q ont la signification indiquée dans la description, leurs sels pharmaceutiquement acceptables, des compositions pharmaceutiques contenant lesdits composés, et l'utilisation de ces compositions pour améliorer les facultés cognitives et traiter les symptômes positifs et négatifs de la schizophrénie et d'autres psychoses chez des mammifères, par exemple chez les êtres humains.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bicyclic [3.1.0] derivatives as glycine transporter inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic [3.1.0] derivatives as glycine transporter inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic [3.1.0] derivatives as glycine transporter inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1784976

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.